BioSpace News Archive

Ashvattha Therapeutics, a clinical-stage biotech company focused on the development of novel hydroxyl dendrimer therapeutics (HDTs) to treat unmet medical needs in oncology, ocular and inflammatory diseases, today announced data from a late-breaking presentation at The Liver Meeting Digital Experience 2020 of the American Association for the Study of Liver Diseases (AASLD), held virtually November 13-16, 2020.

Mymetics continues to progress its Covid-19 vaccine development plan based on its virosome-vaccine platform, evaluating different rationally designed SARS-CoV-2 antigens for an effective and safe virosome-based Covid-19 vaccine.

STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the publication of a peer-reviewed health-economic study

Initiation of Phase 2b clinical trial evaluating AB201 as a potential treatment for COVID 19 anticipated in fourth quarter Topline data from trial anticipated Q2 2021

Emmes today announced that it provided the data and statistical analysis support for a Phase 1 clinical trial of an investigational COVID-19 vaccine, mRNA-1273, that enrolled adult volunteers. The results of this clinical trial were published in the New England Journal of Medicine (NEJM) on September 29 .

Moderna, Inc. , (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced its participation in the following upcoming investor conferences: Credit Suisse 29th Annual Virtual Healthcare Conference on Wednesday, November 11, 2020 at 8:00 a.m. ET. Jefferies Virtual London Healthcare

“It’s time to look more seriously at UV-C light air purification to help protect against airborne pathogens such as COVID-19, influenza, and pneumonia,” stated Dr. Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine Emeritus for Desert Regional Medical Center, and a member of Vystar Corporation’s Board of Directors.

Avantor executives joined other industry leaders at virtual Cell & Gene Therapy Bioprocessing & Commercialization Conference Panels discussed critical topics including process efficiency and scaling solutions

Eon , a Denver -based healthtech leader, recently launched Centralized Management , the only market available patient management service to fully manage every aspect of a lung cancer screening

Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced a first-of-its-kind study to improve outcomes for patients diagnosed with a rare disease known as Tuberous Sclerosis Complex (TSC). Surrogen, a subsidiary of Recombinetics Inc., is focused on d